Renaissance Technologies’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,321,859
| Closed | -$12.1M | – | 4030 |
|
|
2021
Q2 | $12.1M | Sell |
1,321,859
-95,000
| -7% | -$553K | 0.02% | 1045 |
|
|
2021
Q1 | $7.04M | Sell |
1,416,859
-173,000
| -11% | -$836K | 0.01% | 1438 |
|
|
2020
Q4 | $6.85M | Buy |
1,589,859
+38,161
| +2% | +$155K | 0.01% | 1398 |
|
|
2020
Q3 | $6.66M | Buy |
1,551,698
+167,189
| +12% | +$699K | 0.01% | 1400 |
|
|
2020
Q2 | $6.22M | Buy |
1,384,509
+201,611
| +17% | +$901K | 0.01% | 1507 |
|
|
2020
Q1 | $4.73M | Buy |
1,182,898
+3,600
| +0.3% | +$30.6K | ﹤0.01% | 1602 |
|
|
2019
Q4 | $10M | Sell |
1,179,298
-26,400
| -2% | -$206K | 0.01% | 1447 |
|
|
2019
Q3 | $8.26M | Buy |
1,205,698
+19,200
| +2% | +$141K | 0.01% | 1509 |
|
|
2019
Q2 | $9.88M | Sell |
1,186,498
-35,900
| -3% | -$310K | 0.01% | 1426 |
|
|
2019
Q1 | $11.2M | Buy |
1,222,398
+123,810
| +11% | +$1.26M | 0.01% | 1311 |
|
|
2018
Q4 | $12M | Buy |
1,098,588
+44,788
| +4% | +$564K | 0.01% | 1192 |
|
|
2018
Q3 | $14.7M | Buy |
1,053,800
+105,100
| +11% | +$1.42M | 0.02% | 1113 |
|
|
2018
Q2 | $10.1M | Buy |
948,700
+253,500
| +36% | +$2.47M | 0.01% | 1339 |
|
|
2018
Q1 | $6.01M | Sell |
695,200
-31,863
| -4% | -$280K | 0.01% | 1701 |
|
|
2017
Q4 | $6.87M | Sell |
727,063
-99,737
| -12% | -$779K | 0.01% | 1611 |
|
|
2017
Q3 | $6.49M | Buy |
826,800
+10,200
| +1% | +$76.5K | 0.01% | 1592 |
|
|
2017
Q2 | $7.02M | Buy |
816,600
+311,800
| +62% | +$2.24M | 0.01% | 1483 |
|
|
2017
Q1 | $3.56M | Buy |
504,800
+153,200
| +44% | +$960K | 0.01% | 1911 |
|
|
2016
Q4 | $1.49M | Buy |
351,600
+20,000
| +6% | +$96.8K | ﹤0.01% | 2369 |
|
|
2016
Q3 | $1.66M | Buy |
331,600
+28,900
| +10% | +$122K | ﹤0.01% | 2303 |
|
|
2016
Q2 | $1.07M | Buy |
302,700
+84,800
| +39% | +$312K | ﹤0.01% | 2497 |
|
|
2016
Q1 | $752K | Sell |
217,900
-48,002
| -18% | -$170K | ﹤0.01% | 2710 |
|
|
2015
Q4 | $904K | Buy |
265,902
+146,092
| +122% | +$678K | ﹤0.01% | 2507 |
|
|
2015
Q3 | $623K | Sell |
119,810
-58,045
| -33% | -$358K | ﹤0.01% | 2558 |
|
|
2015
Q2 | $1.21M | Buy |
177,855
+63,155
| +55% | +$448K | ﹤0.01% | 2349 |
|
|
2015
Q1 | $819K | Buy |
114,700
+94,300
| +462% | +$650K | ﹤0.01% | 2406 |
|
|
2014
Q4 | $152K | Buy |
+20,400
| New | +$173K | ﹤0.01% | 2732 |
|
Other funds holding KIN
Renaissance Technologies's KIN Position: Q3 2021 in Review
Renaissance Technologies sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 1,321,859 shares — an estimated $12.1M sold.
Renaissance Technologies first reported a position in KIN in Q4 2014 and held it in 27 quarters. The position peaked at $14.7M in Q3 2018. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Renaissance Technologies reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Renaissance Technologies sold 1,321,859 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $12.1M.
- Renaissance Technologies first reported a position in Kindred Biosciences, Inc. in Q4 2014 and held it in 27 quarters.
- Renaissance Technologies's Kindred Biosciences, Inc. position peaked at $14.7M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.